Archives of Women's Mental Health

, Volume 16, Issue 6, pp 531–537 | Cite as

The Iranian version of the Premenstrual Symptoms Screening Tool (PSST): a validation study

  • Fatemeh Zahra Hariri
  • Lida Moghaddam-Banaem
  • Shiva Siah Bazi
  • Amal Saki Malehi
  • Ali Montazeri
Original Article

Abstract

The objective of the current study was to translate and test psychometric properties of the Premenstrual Symptoms Screening Tool (PSST) in Iran. Using a standard “forward–backward” procedure, the English version of PSST was translated into Persian. A random sample of university students aged 18 years and over completed the questionnaire in Tehran, Iran. Psychometric properties of the Iranian version of PSST were assessed by performing reliability (internal consistency) and validity analyses [Content Validity Ratio (CVR) and Content Validity Index (CVI)]. In all, 925 female students took part in the study. Of these, 284 (30.7 %) had premenstrual syndrome (PMS) and 119 (12.9 %) had premenstrual dysphoric disorder (PMDD). Reliability of the PSST as measured by internal consistency was found to be satisfactory (Cronbach’s alpha coefficient, 0.93). The content validity as assessed by CVR and CVI were desirable (0.7 and 0.8, respectively). The Iranian version of PSST seems to be a reliable and valid measure of detecting PMS and PMDD in Iranian young female populations.

Keywords

Premenstrual Symptoms Screening Tool Validation study Iran 

References

  1. Alavi A, Salahi Moghaddam A, Alimalayeri N, Ramezanpour A (2007) Prevalence of clinical manifestation of premenstrual syndrome and premenstrual dysphoric disorder among Bandar Abbas medical students [Persian]. Med J of Hormozgan Univ of Med Sci 10:335–341Google Scholar
  2. American College of Obstetricians and Gynecologists (2000) Clinical management guidelines for obstetrician-gynecologists: premenstrual syndrome. ACOG Practice Bulletin 15:1–9Google Scholar
  3. American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders fourth edition-text revision (DSM-IV-TR). American Psychiatric Press, Washington, DCCrossRefGoogle Scholar
  4. Berek JS (2007) Berek & Novak’s gynecology. Lippincott, New YorkGoogle Scholar
  5. Borenstein JE, Dean BB, Endicott J, Wong J, Brown C, Dickerson V et al (2003) Health and economic impact of the premenstrual syndrome. J Reprod Med 48:515–524PubMedGoogle Scholar
  6. Braverman PK (2007) Premenstrual syndrome and premenstrual dysphoric disorder. J Pediatr Adolesc Gynecol 20:3–12PubMedCrossRefGoogle Scholar
  7. Chayachinda C, Rattanachaiyanont M, Phattharayuttawat S, Kooptiwoot S (2008) Premenstrual syndrome in Thai nurses. J Psychosom Obstet Gynecol 29:203–209CrossRefGoogle Scholar
  8. Derman O, Kanbur N, Tokur TE, Kotluk T (2004) Premenstrual syndrome and associated symptoms in adolescent girls. Eur J Obstet Gynecol Reprod Biol 116:201–206PubMedCrossRefGoogle Scholar
  9. Farhadinasab A, Kashani K (2003) Study the prevalence of pre-menstrual dysphoric disorder in Hamedan high school girls in 2003 [Persian]. J Hamedan Univ of Med Sci 39:25–28Google Scholar
  10. Flintbox (2012) The Premenstrual Symptoms Screening Tool (PSST). [http://www.flintbox.com/public/project/575]
  11. Gonda X, Telek T, Juhasz G, Lazery J, Vargha A, Bagdy G (2008) Patterns of mood changes throughout the reproductive cycle in healthy women without premenstrual dysphoric disorder. Prog Neuropsychopharmacol Biol Psychiatry 32:1782–1788PubMedCrossRefGoogle Scholar
  12. Grant JS, Davis LL (1997) Focus on quantitative methods: selection and use of content experts for instrument development. Res Nurs Health 20:269–274PubMedCrossRefGoogle Scholar
  13. Halbreich U, Borenstein J, Pearlstein T, Kahn L (2003) The prevalence, impairment, impact and burden of premenstrual dysphoric disorder (PMS/PMDD). Psychoneuroendocrinology 28(Suppl 3):1–23Google Scholar
  14. He Z, Chen R, Zhou Y, Geng L, Zhang Z, Chen S et al (2009) Treatment for premenstrual syndrome with vitex agnus castus: a prospective, randomized, multi-center placebo controlled study in China. Maturitas 63:99–103PubMedCrossRefGoogle Scholar
  15. Heinemann LA, Minh T, Filonenko A, Uhl-Hochgraber K (2010) Explorative evaluation of the impact of severe premenstrual disorders on work absenteeism and productivity. Womens Health Issues 20:58–65PubMedCrossRefGoogle Scholar
  16. Johnson SR (2004) Premenstrual syndrome, premenstrual dysphoric disorder, and beyond: a clinical primer for practitioners. Obstet Gynecol 104:845–859PubMedCrossRefGoogle Scholar
  17. Kayatekin ZE, Alex N, Sabo A, Halbreich U (2008) Levetriacetam for treatment of premenstrual dysphoric disorder: a pilot, open label study. Arch Womens Ment Health 11:207–211PubMedCrossRefGoogle Scholar
  18. Lawshe CH (1975) A quantitative approach to content validity. Pers Psychol 28:563–575CrossRefGoogle Scholar
  19. Nourjah P (2008) Premenstrual syndrome among teacher training university students in Iran. J Obstet Gynaecol India 58:49–52Google Scholar
  20. Nunnally JC, Bernstein IH (1994) Psychometric theory. McGraw-Hill, New YorkGoogle Scholar
  21. Pearlstein T, Steiner M (2008) Premenstrual dysphoric disorder: burden of illness and treatment update. J Psychiatry Neurosci 33:291–301PubMedGoogle Scholar
  22. Polit DF, Beck CT, Owen SV (2007) Is the CVI an acceptable indicator of content validity? Appraisal and recommendations. Res Nurs Health 30:459–467PubMedCrossRefGoogle Scholar
  23. Rabinson RL, Swindle RW (2000) Premenstrual symptoms severity: impact on social function and treatment seeking behaviors. J Womens Health Gend-Based Med 9:757–768CrossRefGoogle Scholar
  24. Reed SC, Levin FR, Evans SM (2008) Changes in mood, cognitive performance and appetite in the luteal and follicular phase of the menstrual cycle in women with and without PMDD (premenstrual dysphoric disorders). Horm Behav 54:185–193PubMedCrossRefGoogle Scholar
  25. Shahpourian F, Mahmoudi Z, Bastani F, Parsai S, Hoseini F (2006) Premenstrual syndrome (PMS) and the related symptoms among students of Iran University of Medical Sciences (IUMS) [Persian]. J of Nursing of Iran Univ of Med Sci 18:57–66Google Scholar
  26. Speroff L, Fritz MA (2005) Clinical gynecology endocrinology and infertility. Lippincott, New YorkGoogle Scholar
  27. Steiner M, Macdougal M, Brown E (2003) The Premenstrual Symptoms Screening Tool (PSST) for clinicians. Arch Womens Ment Health 6:203–209PubMedCrossRefGoogle Scholar
  28. Steiner M, Peer M, Palova E, Freeman EW, Macdougall M, Soares CN (2011) The Premenstrual Symptoms Screening Tool revised for adolescents (PSST-A): prevalence of severe PMS and premenstrual dysphoric disorder in adolescents. Arch Womens Ment Health 14:77–81PubMedCrossRefGoogle Scholar
  29. Taghizadeh M, Ghofranipour F, Nikpour B, Faghizadeh S (2003) Study of the frequency of signs, symptoms and self-medication method for premenstrual syndrome (PMS) [Persian]. Daneshvar Medicine 10:19–26Google Scholar
  30. Takeda T, Tasaka K, Sakata M, Murata Y (2006) Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in Japanese women. Arch Womens Ment Health 9:209–212PubMedCrossRefGoogle Scholar
  31. Talaei A, Fayazi Bordbar MR, Nasiraei M, Dadgar S, Samari AA (2009) Epidemiology of premenstrual syndrome (PMS) in students of Mashhad University of Medical Sciences [Persian]. Iranian J Obste, Gynecol Ferti 12:15–22Google Scholar
  32. Tschudin S, Bertea PC, Zemp E (2010) Prevalence and predictors of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample. Arch Womens Ment Health 13:485–494PubMedCrossRefGoogle Scholar
  33. Tschudin S, Bitzer J, Zemp E (2007) Premenstrual syndrome in Switzerland assessed by Premenstrual Symptoms Screening Tool [abstract]. J Psychosom Obstet Gynecol 28:S51Google Scholar
  34. Yankers K (1997) The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 58:19–25Google Scholar

Copyright information

© Springer-Verlag Wien 2013

Authors and Affiliations

  • Fatemeh Zahra Hariri
    • 1
  • Lida Moghaddam-Banaem
    • 1
  • Shiva Siah Bazi
    • 1
  • Amal Saki Malehi
    • 2
  • Ali Montazeri
    • 3
  1. 1.Department of Midwifery and Reproductive Health, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  2. 2.Department of Biostatistics, Faculty of Medical SciencesTarbiat Modares UniversityTehranIran
  3. 3.Mental Health Research Group, Health Metrics Research Center, Iranian Institute for Health Sciences ResearchACECRTehranIran

Personalised recommendations